For the study, researchers from Saint Louis University and Atlanta-based Emory University’s Rollins School of Public Health analyzed 2002-14 data from the Medical Expenditure Panel Survey to estimate the cost of treating antibiotic-resistant infections.
They found antibiotic resistance added $1,383 to the cost of treating an infection. This figure translates into $2.2 billion in national healthcare costs annually, representing a twofold increase from infection treatment costs in 2002, according to the report.
“The need for innovative new infection prevention programs, antibiotics, and vaccines to prevent and treat antibiotic-resistant infections is an international priority,” the researchers concluded. They believe this study provides the first national cost estimate for antibiotic-resistant treatment.
More articles on clinical leadership and infection control:
House passes ‘right-to-try’ bill on 2nd vote: 10 things to know
US News & World Report ranks top nursing informatics grad programs
Study: Men more likely to be readmitted to hospital in 3 months following gun injury
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
